Cargando…
Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial
BACKGROUND: Ascorbic acid (AA) has in vivo cytotoxic properties at concentrations that can only be achieved through intravenous (IV) administration in humans. Treatment with intravenous AA is widely and increasingly used in complementary medicine despite a lack of clinical evidence for the efficacy...
Autores principales: | Nielsen, Torben K., Højgaard, Martin, Andersen, Jon T., Jørgensen, Niklas Rye, Zerahn, Bo, Kristensen, Bent, Henriksen, Trine, Lykkesfeldt, Jens, Mikines, Kári J., Poulsen, Henrik E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503969/ https://www.ncbi.nlm.nih.gov/pubmed/28725594 http://dx.doi.org/10.21037/tau.2017.04.42 |
Ejemplares similares
-
Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial
por: Rasmussen, Sanne Tofte, et al.
Publicado: (2016) -
An Algorithm for Individual Dosage in Cadmium–Zinc–Telluride SPECT-Gated Radionuclide Angiography
por: Hansen, Maria Normand, et al.
Publicado: (2021) -
Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis
por: Lundin, Martin Thorbjørn, et al.
Publicado: (2021) -
The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019) -
Ascorbate maintains a low plasma oxygen level
por: Injarabian, Louise, et al.
Publicado: (2020)